OnCusp Gets FDA Fast Track For CUSP06 In Platinum-Resistant Cancer
12 Feb 2025 //
PR NEWSWIRE
OnCusp’s CUSP06 Receives FDA Fast Track Designation
11 Feb 2025 //
CONTRACTPHARMA
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing
04 Jan 2024 //
PR NEWSWIRE
OnCusp Therapeutics Receives FDA Clearance for Phase 1 Clinical Trial of CUSP06
15 Aug 2023 //
PR NEWSWIRE